Cargando…
Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study
Aim: The present study investigated the effects of additional cilostazol administration on the 12-month risk of restenosis after femoropopliteal heparin-bonded stent graft implantation. Methods: This study was a sub-analysis of the Viabahn stent graft placement for femoropopliteal disease reQUIring...
Autores principales: | Tobita, Kazuki, Takahara, Mitsuyoshi, Iida, Osamu, Soga, Yoshimitsu, Yamaoka, Terutoshi, Ichihashi, Shigeo, Saito, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564643/ https://www.ncbi.nlm.nih.gov/pubmed/36725018 http://dx.doi.org/10.5551/jat.63874 |
Ejemplares similares
-
Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012) -
Impact of postprocedural minimum lumen area on clinical outcome after femoropopliteal drug-eluting stent implantation
por: Haraguchi, Takuya, et al.
Publicado: (2023) -
Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2022) -
A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
por: Ikushima, Ichiro, et al.
Publicado: (2011) -
One-Year Clinical Outcomes following Implantation of Innova™ Self-Expanding Nitinol Stents in Patients with Peripheral Artery Diseases Presenting Femoropopliteal Artery Lesions
por: Tsujimura, Takuya, et al.
Publicado: (2019)